Hematology: The red science

References

• Firkin F, Chesterman C, Penington D, Rush B. de Gruchy's Clinical Haematology in Medical Practice, 5th edition. Blackwell Scientific Publications, Melbourne 1989; 1–524
   Google Scholar
• Tavassoli M. Bone marrow: The seedbed of blood. Chapter 3. Blood, Pure and Eloquent, MM Wintrobe. McGraw-Hill Book Company, New York 1980; 57–79
   Google Scholar
• Pauling L, Itano H A, Singer S J, Wells I C. Sickle cell anemia a molecular disease. Science 1949; 110: 543–8
   PubMed Web of Science ®Google Scholar
• Ingram V M. A specific chemical difference between the globins of normal human and sickle-cell anaemic haemoglobin. Nature 1956; 178: 792–4
   PubMed Web of Science ®Google Scholar
• Beadle G W, Tatum E L. Genetic control of biochemical reactions in neurospora. Proc Natl Acad Sci USA 1941; 27: 499–506
   PubMedGoogle Scholar
• Jeffreys A J, Flavell R A. The rabbit β-globin gene contains a large insert in the coding sequence. Cell 1977; 12: 1097–108
   PubMed Web of Science ®Google Scholar
• Tilghman S M, Tiemeier D C, Polsky F. Cloning specific segments of the mammalian genome: Bacteriophage λ containing mouse globin and surrounding gene sequences. Proc Natl Acad Sci USA 1977; 74: 4406–10
   PubMed Web of Science ®Google Scholar
• Honig G R, Adams JG, III. Human Hemoglobin Genetics. Springer-Verlag, Wien, New York 1986; 292–349
   Google Scholar
• Nowell P C, Hungerford D A. Chromosome studies on normal and leukemic human leukocytes. J Natl Cancer Inst 1960; 25: 85–93
   PubMed Web of Science ®Google Scholar
• Gunz F W, Fitzgerald P H, Adams A. An abnormal chromosome in chronic lymphocytic leukaemia. Br Med J 1962; ii: 1097–9
   Google Scholar
• Baikie A G, Court-Brown W M, Buckton K E, Harnden D G, Jacobs P A, Tough I M. A possible specific chromosome abnormality in human chronic myeloid leukaemia. Nature 1960; 188: 1165–6
   PubMed Web of Science ®Google Scholar
• O'Riordan M L, Robinson J A, Buckton K E, Evans H J. Distinguishing between the chromosomes involved in Down's syndrome (trisomy 21) and chronic myeloid leukaemia (Ph1) by fluorescence. Nature 1971; 230: 167–8
   PubMed Web of Science ®Google Scholar
• Rowley J D. Ph1-positive leukaemia including chronic myelogenous leukaemia. Clinics in Haemat 1980; 9: 55–86
   PubMedGoogle Scholar
• Garson O M. Cytogenetics of leukemic cells. Chapter 7. Leukemia 5th ed., ES Henderson, TA Lister. WB Saunders Company, Philadelphia 1990; 131–52
   Google Scholar
• DeKlein A, Van Kessel A G, Grosveld G. A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia. Nature 1982; 300: 765–7
   PubMed Web of Science ®Google Scholar
• Heisterkamp N, Stam K, Groffen J, De Klein A, Grosveld G. Structural organization of the bcr gene and its role in the Ph1 translocation. Nature 1985; 315: 758–61
   PubMed Web of Science ®Google Scholar
• Gale R P, Canaani E. An 8-kilobase abl RNA transcript in chronic myelogenous leukemia. Proc Natl Acad Sci USA 1984; 81: 5648–52
   PubMed Web of Science ®Google Scholar
• Gale R P, Cannani E. The molecular biology of chronic myelogenous leukaemia. Br J Haemat 1985; 60: 395–408
   PubMed Web of Science ®Google Scholar
• Croce C M, Nowell P C. Molecular basis of human B cell neoplasia. Blood 1985; 65: 1–7
   PubMed Web of Science ®Google Scholar
• De Thé H, Chomienne C, Lanotte M, Degos L, Dejean A. The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor α gene to a novel transcribed locus. Nature 1990; 347: 558–61
   PubMed Web of Science ®Google Scholar
• Hunger S P, Galili N, Carroll A J, Crist W M, Link M P, Cleary M L. The t(l; 19)(q23;p13) results in consistent fusion of E24 and PBX1 coding sequences in acute lymphoblastic leukemias. Blood 1991; 77: 687–93
   PubMed Web of Science ®Google Scholar
• Bos J L, Verlaan-de Vries M, Van der Eb A J. Mutations in N-ras predominate in acute myeloid leukemia. Blood 1987; 69: 1237–41
   PubMed Web of Science ®Google Scholar
• Janssen J WG, Steenvoorden A CM, Lyons J. Ras gene mutations in acute and chronic myelocytic leukemias, chronic myeloproliferative disorders, and myelodysplastic syndromes. Proc Natl Acad Sci USA 1987; 84: 9228–32
   PubMed Web of Science ®Google Scholar
• Padua R A, Carter G, Hughes D. Ras mutations in myelodysplasia detected by amplification, oligonucleotide hybridization, and transformation. Leukemia 1988; 2: 503–10
   PubMed Web of Science ®Google Scholar
• Jacobs A. Genetic lesions in preleukaemia. Leukemia 1991; 5: 277–82
   PubMed Web of Science ®Google Scholar
• Fialkow P J. Clonal development and stem cell origin of leukemias and related disorders. Chapter 4. Leukemia 5th ed., ES Henderson, TA Lister. WB Saunders Company, Philadelphia 1990; 35–54
   Google Scholar
• Arnold A, Cossman J, Bakhshi. Immunoglobulin-gene rearrangements as unique clonal markers in human lymphoid neoplasms. N Engl J Med 1983; 309: 1593–9
   PubMed Web of Science ®Google Scholar
• Raghavachar A, Thiel E, Bartram C R. Analyses of phenotype and genotype in acute lymphoblastic leukemias at first presentation and in relapse. Blood 1987; 70: 1079–83
   PubMed Web of Science ®Google Scholar
• Giles G G, Armstrong B K, Smith L R. Cancer in Australia 1982. National Cancer Statistics Clearing House 1987; 64–71
   Google Scholar
• Vincent P C. Granulocyte kinetics in health and disease. Clinics in Haemat 1977; 6: 695–717
   PubMedGoogle Scholar
• Grace J, Hall B E, Lew M. Cytogenetic abnormalities in benign lymphoid hyperplasia: A dual-parameter study using chromosome analysis and flow cytometry. Int J Cancer 1989; 44: 959–64
   PubMedGoogle Scholar
• Pejovic T, Heim S, Mandahl N. Trisomy 12 is a consistent chromosomal aberration in benign ovarian tumours. Genes Chromo Cancer 1990; 2: 48–52
   PubMedGoogle Scholar
• Bressac B, Kew M, Wands J, Ozturk M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 1991; 350: 429–31
   PubMed Web of Science ®Google Scholar
• Hsu I C, Metcalf R A, Sun T, Welsh J A, Wang N J, Harris C C. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 1991; 350: 427–8
   PubMed Web of Science ®Google Scholar
• Vincent P C. Kinetics of leukemia and control of cell division and replication. Chapter 5. Leukemia 5th ed, ES Henderson, TA Lister. WB Saunders Company, Philadelphia 1990; 55–104
   Google Scholar
• Erslev A. Blood and mountains. Chapter 9. Blood Pure and Eloquent, MM Wintrobe. McGraw-Hill Book Company, New York 1980; 257–80
   Google Scholar
• Reissmann K R. Studies on the mechanism of erythropoietic stimulation in parabiotic rats during hypoxia. Blood 1950; 5: 372–80
   PubMed Web of Science ®Google Scholar
• Erslev A. Humoral regulation of red cell production. Blood 1953; 8: 349–57
   PubMed Web of Science ®Google Scholar
• Stohlman F, Jr., Ebbe S, Morse B, Howard D, Donovan J. Regulation of erythropoiesis XX. Kinetics of red cell production. Ann NY Acad Sci 1968; 149: 156–72
   PubMedGoogle Scholar
• Miyake T, Kung CK-H, Goldwasser E. Purification of human erythropoietin. J Biol Chem 1977; 252: 5558–64
   PubMed Web of Science ®Google Scholar
• Jacobs K, Shoemaker C, Rudersdorf R. Isolation and characterization of genomic and cDNA clones of human erythropoietin. Nature 1985; 313: 806–10
   PubMed Web of Science ®Google Scholar
• Lin F-U, Suggs S, Lin C-H. Cloning and expression of the human erythropoietin gene. Proc Natl Acad Sci USA 1985; 82: 7580–4
   PubMed Web of Science ®Google Scholar
• Sieff C A, Emerson S G, Mufson A, Gesner T G, Nathan D G. Dependence of highly enriched human bone marrow progenitors on hemopoietic growth factors and their response to recombinant erythropoietin. J Clin Invest 1986; 77: 74–81
   PubMedGoogle Scholar
• Bradley T R, Metcalf D. The growth of mouse bone marrow cells in vitro. Aust J Exp Biol Med Sci 1966; 44: 287–300
   PubMedGoogle Scholar
• Pluznik D H, Sachs L. The cloning of normal “mast” cells in tissue culture. J Cell Comp Physiol 1965; 66: 319–24
   Google Scholar
• Metcalf D. The hemopoietic colony stimulating factors. Elsevier, Amsterdam 1984; 1–493
   Google Scholar
• Young G AR, Vincent P C. Drug-induced agranulocytosis. Clinics in Haemat 1980; 9: 483–504
   PubMedGoogle Scholar
• Vincent P C, Sutherland R, Bradley M, Lind D, Gunz F W. Marrow culture studies in adult acute leukemia at presentation and during remission. Blood 1977; 6: 903–12
   Google Scholar
• Buick R N, Minden M D, McCulloch E A. Self-renewal in culture of proliferative blast progenitor cells in acute myeloblastic leukemia. Blood 1979; 1: 95–104
   Google Scholar
• Vadas M A, Lopez A E, Shannon M F, Atkinson Y. Human myeloid growth factors. Immunol & Cell Biol 1987; 65: 141–5
   PubMedGoogle Scholar
• Crosier P S, Clark S C. Basic biology of the hematopoietic growth factors. Sem Oncol 1992, in press
   PubMedGoogle Scholar
• Todd A V, Ireland C M, Hand H J. Allele-specific enrichment: A method for the detection of low level N-ras gene mutations in acute myeloid leukemia. Leukemia 1991; 5: 160–1
   PubMedGoogle Scholar
• Clark S C, Kamen R. The human hematopoietic colony-stimulating factors. Science 1987; 236: 1229–37
   PubMed Web of Science ®Google Scholar
• Metcalf D. Haemopoietic growth factors 2: Clinical applications. The Lancet 1989; 885–7
   PubMedGoogle Scholar
• Bronchud M H, Scarffe J H, Thatcher N. Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer. Br J Cancer 1987; 56: 809–13
   PubMed Web of Science ®Google Scholar
• Vadhan-Raj S, Keating M, LeMaistre A. Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes. N Engl J Med 1987; 317: 1545–52
   PubMed Web of Science ®Google Scholar